CURRENT STATUS OF ANTIFIBRINOLYTIC DRUGS

被引：19
|
作者：
OGSTON, D
机构：
来源：
BLOOD REVIEWS | 1989年 / 3卷 / 01期
关键词：
D O I：
10.1016/0268-960X(89)90019-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1 / 4
页数：4
相关论文
共 50 条
  • [21] The Current Status of New Antidiabetic Drugs
    Pemminati, Sudhakar
    Millis, Richard Mark
    Kamath, Ashwin
    Shenoy, Ashok Kudgi
    Gorantla, Vasavi Rakesh
    JOURNAL OF PHARMACOPUNCTURE, 2016, 19 (04) : 291 - +
  • [22] CURRENT STATUS OF DIALYSIS OF POISONS AND DRUGS
    MAHER, JF
    SCHREINER, GE
    TRANSACTIONS AMERICAN SOCIETY FOR ARTIFICIAL INTERNAL ORGANS, 1969, 15 : 461 - +
  • [23] CURRENT STATUS OF FIBRINOLYTIC DRUGS IN CARDIOLOGY
    GURFINKEL, E
    MAUTNER, B
    PRENSA MEDICA ARGENTINA, 1991, 78 (05): : 211 - 216
  • [24] Current status of radiotherapy and new drugs
    Roedel, C.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S58 - S58
  • [25] CURRENT STATUS OF NONPROPRIETARY NOMENCLATURE FOR DRUGS
    JEROME, JB
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1963, 185 (04): : 294 - &
  • [26] Current status and perspectives of biopharmaceutical drugs
    Ryu, Jae Kuk
    Kim, Hyo Sun
    Nam, Doo Hyun
    BIOTECHNOLOGY AND BIOPROCESS ENGINEERING, 2012, 17 (05) : 900 - 911
  • [27] FIBRINOLYSIS AND ANTIFIBRINOLYTIC DRUGS IN GROWTH AND SPREAD OF TUMORS
    PETERSON, HI
    CANCER TREATMENT REVIEWS, 1977, 4 (03) : 213 - 217
  • [28] Antifibrinolytic drugs for treating primary postpartum haemorrhage
    Shakur, Haleema
    Beaumont, Danielle
    Pavord, Sue
    Gayet-Ageron, Angele
    Ker, Katharine
    Mousa, Hatem A.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (02):
  • [29] Antifibrinolytic agents in current anaesthetic practice
    Ortmann, E.
    Besser, M. W.
    Klein, A. A.
    BRITISH JOURNAL OF ANAESTHESIA, 2013, 111 (04) : 549 - 563
  • [30] Antifibrinolytic drugs for treating primary postpartum hemorrhage
    Shakur, Haleema
    Beaumont, Danielle
    Pavord, Sue
    Gayet-Ageron, Angele
    Ker, Katharine
    Mousa, Hatem A.
    EMERGENCIAS, 2020, 32 (03): : 203 - 205
12345